Publication | Open Access

Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases

Combination InhibitionPatient-derived XenograftsMedicineMice BearingBreast CancerCancer BiologyCancer TreatmentPharmacologyCell BiologyTumor BiologyCancer Growth